Overview
Lisa Shigematsu practices practicing medicine in Tokyo, Japan.
Her clinical expertise encompasses Long Haul COVID, EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Lung Cancer.
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lisa Shigematsu
Is Lisa Shigematsu a top-rated expert for Long Haul COVID?
MediFind is an objective health platform that identifies experts based on real-world data. Lisa Shigematsu is classified as an Experienced expert for Long Haul COVID, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lisa Shigematsu participate in research or clinical trials?
Yes. Lisa Shigematsu has published 11 articles and abstracts on conditions like Long Haul COVID. You can view a list of Lisa Shigematsu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerMs. Shigematsu isExperienced. Learn about EGFR Positive Lung Cancer.
- Long Haul COVIDMs. Shigematsu isExperienced. Learn about Long Haul COVID.
- Lung AdenocarcinomaMs. Shigematsu isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerMs. Shigematsu isExperienced. Learn about Lung Cancer.
- Memory LossMs. Shigematsu isExperienced. Learn about Memory Loss.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Shigematsu isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Severe Acute Respiratory Syndrome (SARS)Ms. Shigematsu isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Squamous Cell Lung CarcinomaMs. Shigematsu isExperienced. Learn about Squamous Cell Lung Carcinoma.